CME stock rated an Overweight by Morgan Stanley

In a filing, CME Group Inc revealed its Director Carey Charles P acquired Company’s shares for reported $0.14 million on May 28 ’25. In the deal valued at $286.37 per share,500 shares were bought.

Then, Kaye Daniel G sold 500 shares, generating $141,210 in total proceeds. Upon selling the shares at $282.42, the Director now owns 3,668 shares.

Before that, Kaye Daniel G bought 500 shares. CME Group Inc shares valued at $141,250 were divested by the Director at a price of $282.50 per share.

Morgan Stanley upgraded its CME Group Inc [CME] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early March from “a Mkt perform” to “an Outperform”. Citigroup also remained covering CME and has decreased its forecast on January 06, 2025 with a “Neutral” recommendation from previously “Buy” rating. Redburn Atlantic revised its rating on October 08, 2024. It rated CME as “a Neutral” which previously was an “a Buy”.

Price Performance Review of CME

On Monday, CME Group Inc [NASDAQ:CME] saw its stock fall -2.15% to $268.35. Over the last five days, the stock has lost -7.69%. CME Group Inc shares have risen nearly 15.55% since the year began. Nevertheless, the stocks have risen 37.17% over the past one year. While a 52-week high of $290.79 was reached on 06/02/25, a 52-week low of $186.08 was recorded on 01/07/25. SMA at 50 days reached $271.76, while 200 days put it at $243.09.

Levels Of Support And Resistance For CME Stock

The 24-hour chart illustrates a support level at 264.97, which if violated will result in even more drops to 261.60. On the upside, there is a resistance level at 271.77. A further resistance level may holdings at 275.20. The Relative Strength Index (RSI) on the 14-day chart is 38.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -8.88, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.08%. Stochastics %K at 13.66% indicates the stock is a buying.

The most recent change occurred on September 27, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $235 price target.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.